OraSure Technologies OSUR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Product | ||||||
| COVID-19 | $13.32M-3.2% | $13.76M+27.8% | $10.76M-16.1% | $12.83M-5.7% | $13.61M-2.9% | |
| HIV | $49.92M+0.2% | $49.8M-7.5% | $53.86M-11.8% | $61.07M-6.9% | $65.61M-13.5% | |
| Non-product and services revenues | $6.58M+10.3% | $5.97M+39.0% | $4.29M+53.0% | $2.81M+56.1% | $1.8M+47.8% | |
| Risk Assessment Testing | $446K-76.1% | $1.87M-52.8% | $3.96M-32.6% | $5.87M-42.2% | $10.15M-13.5% | |
| Sample Management Solutions | $38.3M-0.1% | $38.36M-13.0% | $44.08M-5.4% | $46.58M-7.5% | $50.38M-7.8% | |
| Net revenues by Geography | ||||||
| Africa | $24.65M-1.7% | $25.06M-14.7% | $29.39M-18.1% | $35.89M+4.9% | $34.23M+4.5% | |
| Europe | $7.2M-2.5% | $7.38M-2.7% | $7.59M-9.8% | $8.41M-0.6% | $8.46M+0.4% | |
| Other regions | $4.81M+5.7% | $4.55M-4.7% | $4.77M+4.1% | $4.58M-3.6% | $4.76M-15.1% | |
| United States | $76.37M-2.1% | $78.03M-7.1% | $83.96M-6.3% | $89.65M-21.5% | $114.18M-17.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does OraSure Technologies break its business down?
- OraSure Technologies (OSUR) reports net revenues by product across 7 parts — COVID-19, HCV, HIV, Non-product and services revenues and Other Product And Services Revenues. Each is extracted from the segment footnotes and tracked over time.
- Where does OraSure Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OraSure Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
